Immunology journals by time to acceptance (2025)
57 journals with 2025 figures · median days from submission to acceptance, measured from PubMed dates · data as of Sep 15, 2026
Sorted by median days from submission to acceptance in 2025. Faster is not better — this is a planning aid, not a ranking of quality. Click a column to re-sort.
| Open access | ||||||
|---|---|---|---|---|---|---|
| HLA | 8 (5–17) | 487 | — | ≈$4,780 | — | 0.0 |
| Immunological Reviews | 33 (10–81) | 98 | — | ≈$5,000 | — | 0.0 |
| Cytokine & Growth Factor Reviews | 33 (23–62) | 63 | 3 | ≈$4,900 | — | 0.0 |
| Trends in Immunology | 47 (30–62) | 114 | 23 | ≈$7,030 | — | 0.0 |
| Current Opinion in Immunology | 55 (40–77) | 147 | 21 | ≈$4,410 | — | 0.0 |
| Veterinary Immunology and Immunopathology | 57 (47–77) | 96 | 2 | ≈$3,250 | Hybrid | 0.0 |
| Journal of Translational Autoimmunity | 61 (45–83) | 77 | 1 | $3,540 | Open access (DOAJ) | 0.0 |
| ImmunoHorizons | 69 (8–115) | 84 | — | $1,595 | Open access (DOAJ) | 0.0 |
| Journal of Fish Diseases | 77 (57–109) | 201 | 13 | ≈$5,450 | — | 0.0 |
| Immunity & Ageing | 77 (43–101) | 57 | 23 | $3,390 | Open access (DOAJ) | 0.0 |
| Frontiers in Immunology | 78 (54–112) | 6,814 | 20 | ≈$3,850 | Open access (DOAJ) | 0.45 |
| Fish & Shellfish Immunology | 79 (57–112) | 717 | 1 | ≈$4,330 | — | 0.0 |
| Clinical Immunology | 80 (57–115) | 133 | 3 | ≈$4,400 | Hybrid | 0.0 |
| Seminars in Immunology | 82 (55–154) | 51 | 10 | ≈$4,370 | Hybrid | 0.0 |
| Cellular Immunology | 87 (63–139) | 79 | 2 | ≈$3,550 | Hybrid | 0.0 |
| Inflammation | 90 (68–122) | 206 | 38 | ≈$4,790 | — | 2.14 |
| Cancer Immunology Immunotherapy | 91 (61–142) | 333 | 26 | $4,790 | Open access (DOAJ) | 0.0 |
| International Immunology | 93 (62–154) | 61 | — | ≈$3,530 | — | 0.0 |
| Molecular Immunology | 96 (66–139) | 204 | 8 | ≈$3,340 | Hybrid | 0.0 |
| Immunologic Research | 96 (66–147) | 142 | 13 | ≈$2,890 | — | 0.0 |
| International Immunopharmacology | 97 (69–142) | 1,779 | 8 | ≈$3,220 | Hybrid | 1.71 |
| Developmental & Comparative Immunology | 100 (64–136) | 195 | 1 | ≈$3,340 | Hybrid | 0.0 |
| Inflammation Research | 101 (81–136) | 183 | 24 | ≈$4,790 | — | 2.94 |
| Journal of Autoimmunity | 102 (72–146) | 105 | 8 | ≈$5,420 | — | 0.0 |
| Journal of Human Immunity | 104 (72–139) | 59 | 22 | $3,500 | Open access (DOAJ) | — |
| Journal of Neuroimmunology | 107 (75–170) | 225 | 2 | ≈$3,360 | — | 1.14 |
| Human Immunology | 109 (75–155) | 131 | 10 | ≈$3,600 | — | 0.0 |
| Cytokine | 111 (78–166) | 230 | 7 | ≈$3,220 | — | 0.0 |
| ImmunoTargets and Therapy | 111 (89–133) | 94 | 13 | $4,320 | Open access (DOAJ) | — |
| BMC Immunology | 112 (80–160) | 114 | 26 | $3,190 | Open access (DOAJ) | 2.6 |
| Journal of Inflammation | 117 (89–190) | 52 | 25 | $3,290 | Open access (DOAJ) | — |
| Immunology | 119 (89–152) | 153 | 13 | ≈$5,330 | — | 0.0 |
| Journal of Reproductive Immunology | 124 (86–180) | 121 | 3 | ≈$3,690 | — | 1.61 |
| Immunology and Cell Biology | 130 (88–200) | 50 | 21 | ≈$3,750 | Hybrid | 0.0 |
| Immunobiology | 132 (91–168) | 116 | 2 | $2,900 | Open access (DOAJ) | 0.0 |
| Immunology Letters | 136 (83–204) | 101 | 1 | ≈$3,290 | Hybrid | 0.0 |
| American Journal of Reproductive Immunology | 142 (103–201) | 100 | — | ≈$4,460 | — | 0.0 |
| The Journal of Immunology | 145 (88–225) | 363 | — | ≈$3,500 | Hybrid | 0.48 |
| Transplant Immunology | 145 (103–202) | 122 | 2 | ≈$3,440 | — | 1.38 |
| Clinical & Translational Immunology | 147 (98–221) | 52 | 24 | $3,380 | Open access (DOAJ) | 0.0 |
| Journal of Leukocyte Biology | 150 (105–204) | 153 | — | ≈$3,800 | Hybrid | 0.0 |
| Scandinavian Journal of Immunology | 152 (69–202) | 74 | — | ≈$4,480 | Hybrid | 0.0 |
| Journal of Immunology Research | 156 (115–251) | 74 | 33 | $3,110 | Open access (DOAJ) | 4.8 |
| Cellular and Molecular Immunology | 160 (99–215) | 103 | 24 | ≈$5,190 | Hybrid | 0.0 |
| Clinical & Experimental Immunology | 160 (106–231) | 90 | — | ≈$3,816 | — | 0.0 |
| Journal of Immunological Methods | 162 (111–227) | 100 | 2 | ≈$2,970 | — | 0.0 |
| Mediators of Inflammation | 167 (106–234) | 197 | 33 | $3,340 | Open access (DOAJ) | 3.58 |
| European Journal of Immunology | 175 (126–229) | 215 | — | ≈$4,550 | Hybrid | 0.0 |
| Mucosal Immunology | 181 (115–224) | 102 | 3 | ≈$4,370 | Hybrid | 0.0 |
| The Journal of Experimental Medicine | 194 (140–284) | 163 | 34 | — | Hybrid | 0.0 |
| JCI Insight | 202 (146–309) | 489 | 9 | $4,900 | Open access (DOAJ) | 0.38 |
| Journal of Clinical Immunology | 212 (144–285) | 97 | 31 | ≈$4,990 | Hybrid | 0.0 |
| Cancer Immunology Research | 224 (153–303) | 136 | — | — | Hybrid | 0.0 |
| Genes and Immunity | 227 (169–278) | 53 | 15 | ≈$3,190 | Hybrid | 0.0 |
| Cell Reports Medicine | 232 (169–319) | 456 | 27 | $5,790 | Open access (DOAJ) | 0.0 |
| Immunity | 255 (104–343) | 216 | 26 | ≈$10,400 | Hybrid | 0.0 |
| Nature Immunology | 300 (197–380) | 167 | 43 | ≈$12,690 | Hybrid | 0.0 |
Journals are listed where at least 25% of their articles' topics fall in Immunology (OpenAlex).
Latest available year: 2024
2 journals without enough usable 2025 data. Their 2024 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Iranian Journal of Allergy Asthma and Immunology | 86 (49–141) | 91 | 133 | $300 | Open access (DOAJ) | 0.0 |
| Central European Journal of Immunology | 95 (63–130) | 64 | 144 | ≈$808 | Open access (DOAJ) | 0.0 |
Latest available year: 2023
1 journal without enough usable 2025 data. Their 2023 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Journal of Immunotherapy | 133 (80–186) | 52 | 39 | — | Hybrid | 0.0 |
Latest available year: 2022
2 journals without enough usable 2025 data. Their 2022 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Seminars in Immunopathology | 66 (44–91) | 63 | 30 | ≈$3,790 | Hybrid | 0.0 |
| Immune Network | 87 (41–134) | 53 | 24 | — | Open access | 0.0 |
Latest available year: 2021
2 journals without enough usable 2025 data. Their 2021 figures are shown separately so they are never compared with 2025 figures.
| Open access | ||||||
|---|---|---|---|---|---|---|
| Science Immunology | 165 (93–251) | 79 | — | — | Hybrid | 0.0 |
| Science Translational Medicine | 276 (180–398) | 187 | — | — | Hybrid | 1.29 |
Have a deadline?
Pick up to five journals and see whether a submission sequence can realistically reach acceptance before your defence, visa or job-market date. Free.
Open the submission plannerFrequently asked questions
Which Immunology journals accepted papers fastest in 2025?
Among 57 Immunology journals with enough dated articles in 2025, the shortest median time from submission to acceptance was 8 days (HLA). The middle journal's median was 111 days. Speed is not a measure of quality; check scope, indexing and fees too.
How are these times measured?
From the submission and acceptance dates publishers deposit in PubMed, for accepted articles only. Each journal needs at least 50 dated articles in the year shown, and a table headed with a year contains only that year's figures.
Get the free Journal Submission Go/No-Go Checklist
The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.
Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.